Polaris Pharmacy Services Named Exclusive U.S. Distributor of AstraZeneca’s FluMist® Home Service—The World’s First At-Home Nasal Spray Flu Vaccine
By: Businesswire.com FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–Polaris Pharmacy Services, a leading provider of long-term care and specialty pharmacy solutions, has been selected as the exclusive U.S. distributor for FluMist®Home, AstraZeneca’s at-home flu vaccine service available for the 2025-2026 flu season. Through FluMist Home, individuals can order FluMist online to be delivered directly to their home on a date they choose—no doctor’s visit or needle required. The program is the first of its kind to receive FDA approval and has officially launched in the U.S. “We are proud to partner with AstraZeneca to bring this innovative, direct-to-consumer solution to families across the country,” said David Rombro, RPh, Chief Executive Officer of Polaris Pharmacy Services.“As the exclusive pharmacy distributor for FluMist Home, Polaris is leading the charge in redefining how preventive care is delivered in the U.S.” Andrew Leone, Executive Director Marketing and Sales, US Vaccines & Immune Therapies AstraZeneca said, “Our partnership with Polaris Pharmacy Services reflects a shared vision to bring cutting-edge innovation and convenience directly to families and communities across the U.S. Together, we are empowering individuals and their families to help bring flu protection home.” Launched in collaboration with its HUB services partner, Asembia, and ASPN Pharmacies—which provides the technology